Publications by authors named "Hans Smit"

Claim this Profile
P
Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI Categories.
Mart P Kicken, Corine Bethlehem, Karin Beunen, Peter de Jong, Theo van Voorthuizen, Hans J M Smit

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell Lung cancer.
Bas Jm Peters, Esmée van Geffen, Doranne Hilarius, Stephan Böhringer, Juliëtte Zwaveling, Hans Jm Smit

Lung Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer.
Guus R M van den Heuvel, Bas L R Mandos, Olga C J Schuurbiers, Francesco Ciompi, Erik Aarntzen, Hans J M Smit

Transl Lung Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer.
Iva Halilaj, Anshu Ankolekar, Anouk Lenaers, Avishek Chatterjee, Cary J G Oberije, Hans J M Smit

Front Digit Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species.
Michiel M Harmsen, Bart Ackerschott, Hans de Smit

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
Nicolas Girard, Jair Bar, Pilar Garrido, Marina C Garassino, Fiona McDonald, Hans J M Smit

J Thorac Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer.
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, Delvys Rodriguez-Abreu, Jorge Alatorre-Alexander, Hans J M Smit

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Cancer Care Networks; A Case Study of a Lung Cancer Care Network.
Anke Wind, René Limbeek, Henrike Bretveld, Robert van Schijndel, Daan Smits, Hans Smit

Int J Health Policy Manag· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of an Autologous Blood Patch for Prolonged Air Leak: A Systematic Review.
Niek Hugen, Edo J Hekma, Niels J M Claessens, Hans J M Smit, Michel M P J Reijnen

Ann Thorac Surg· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Birt-Hogg-Dubé syndrome in apparent primary spontaneous pneumothorax patients; results and recommendations for clinical practice.
Jincey D Sriram, Irma van de Beek, Paul C Johannesma, Michiel H van Werkum, Tijmen J W T van der Wel, Hans J M Smit

BMC Pulm Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.
Simon A Keek, Esma Kayan, Avishek Chatterjee, José S A Belderbos, Gerben Bootsma, Hans J M Smit

Ther Adv Med Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An invisible group of COVID-19 victims; impact on Dutch lung cancer care.
Jesper van Breeschoten, Rawa Ismail, Hans Smit, Olga Schuurbiers, Franz Schramel

Lung Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation.
Malidi Ahamadi, Nitin Mehrotra, Nathan Hanan, Ka Lai Yee, Ferdous Gheyas, Hans Smit

Clin Pharmacol Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel single-domain antibody multimer that potently neutralizes tetanus neurotoxin.
Hans de Smit, Bart Ackerschott, Robert Tierney, Paul Stickings, Michiel M Harmsen

Vaccine X· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer in the Netherlands.
Lizza E L Hendriks, Anne-Marie C Dingemans, Dirk K M De Ruysscher, Mieke J Aarts, Lidia Barberio, Hans J M Smit, Egbert F Smit

J Thorac Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer.
Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, Delvys Rodríguez-Abreu, Jorge Alatorre-Alexander, Hans J M Smit

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritizing Cleft/Craniofacial Surgical Care after the COVID-19 Pandemic.
Corstiaan Breugem, Hans Smit, Hans Mark, Gareth Davies, Peter Schachner

Plast Reconstr Surg Glob Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations.
Lotte Westerink, Jelmer L J Nicolai, Carl Samuelsen, Hans J M Smit, Pieter E Postmus

Eur J Health Econ· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial.
Anita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, Ben E E M van de Borne, Franz M N H Schramel, Hans J M Smit

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs.
Malidi Ahamadi, Daniela J Conrado, Sreeraj Macha, Vikram Sinha, Julie Stone, Hans Smit

Clin Pharmacol Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumonectomy for Lung Cancer Treatment in The Netherlands: Between-Hospital Variation and Outcomes.
Naomi Beck, Thomas J van Brakel, Hans J M Smit, David van Klaveren, Michel W J M Wouters

World J Surg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reorganization from Kinetically Stable Aggregation States to Thermodynamically Stable Nanotubes of BINOL-Derived Amphiphiles in Water.
Filippo Tosi, Marc C A Stuart, Hans Smit, Jiawen Chen, Ben L Feringa

Langmuir· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
Harry J M Groen, Erik H F M van der Heijden, Theo J Klinkenberg, Bonne Biesma, Joachim Aerts, Hans J M Smit, Egbert F Smit

Br J Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of a Hominal Bis(difluoromethyl) Fragment.
Viktor Ivasyshyn, Hans Smit, Ryan C Chiechi

ACS Omega· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment.
Naomi Beck, Fieke Hoeijmakers, Erwin M Wiegman, Hans J M Smit, Franz M Schramel

J Thorac Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis